Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
24.6%
% of BBP's 65 holdings also in BBH
60.0%
% of BBH's 27 holdings also in BBP
Overlap by Weight
Sector Drift (BBP minus BBH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in BBH |
Overlap | |
|---|---|---|---|---|
 |
INTRA-CELLULAR THERAPIES INC | 2.6% | 2.9% | 2.6% |
|
BEIGENE LTD. SPONSORED ADR | 2.3% | 2.1% | 2.1% |
|
GILEAD SCIENCES INC | 2.1% | 12.5% | 2.1% |
|
AMGEN INC | 2.0% | 16.1% | 2.0% |
|
BIOMARIN PHARMACEUTICAL INC | 1.8% | 1.9% | 1.8% |
Position Highlights (Non-Overlapping Exposures)
BBP Overweight Relative to BBH
 |
ZAI LAB LTD. UNSPONSORED ADR | 2.2% |
|
SAGE THERAPEUTICS INC | 2.2% |
|
AXSOME THERAPEUTICS, INC. | 2.1% |
|
SPRINGWORKS THERAPEUTICS, INC. | 2.1% |
|
HALOZYME THERAPEUTICS INC | 2.1% |
|
TG THERAPEUTICS INC | 2.1% |
|
BRIDGEBIO PHARMA, INC. | 1.9% |
|
ASCENDIS PHARMA A/S | 1.8% |
|
PTC THERAPEUTICS INC | 1.8% |
|
DYNAVAX TECHNOLOGIES CORP | 1.8% |
BBP Underweight Relative to BBH
|
AMGEN INC | -14.1% |
|
GILEAD SCIENCES INC | -10.4% |
|
VERTEX PHARMACEUTICALS INC | -9.5% |
 |
ARGENX SE ADR | -5.1% |
|
NATERA INC | -4.5% |
|
IQVIA HOLDINGS INC | -4.4% |
|
REGENERON PHARMACEUTICALS | -3.6% |
 |
ICON PLC | -3.6% |
|
ALNYLAM PHARMACEUTICALS INC | -2.7% |
|
ILLUMINA INC | -2.7% |